Home › Breast Cancer › Iowa › Ames
Breast Cancer clinical trials in Ames, IA
4 studies for Breast Cancer are looking for participants at sites in and around Ames (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
RecruitingPhase 2
- Accellacare of McFarland, Ames
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecruitingPhase 3
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA111 studies
- Nashville, TN80 studies
- Los Angeles, CA72 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Ames
- Lung Cancer7 studies
- Prostate Cancer7 studies
- Non-Small Cell Lung Cancer6 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Bladder Cancer4 studies
- Melanoma3 studies
- Hypopharyngeal Cancer3 studies
- Laryngeal Cancer3 studies
- Oral Cancer3 studies
- Chronic Lymphocytic Leukemia3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.